Chronic Care to Cure: Navigating Africa’s Pharma Market Dynamics

 Africa Pharmaceutical Market


The Africa pharmaceutical market was valued at USD 26.85 billion in 2023 and is forecast to expand to USD 213.06 billion by 2030, registering a 6.81% CAGR from 2024 through 2030. This rapid growth is driven by heightened health awareness across the continent, rising demand for treatments of chronic and infectious diseases, and improving affordability of medicines. As noted by the South African government, ongoing high incidences of conditions such as obesity, hypertension, diabetes, cancer, and various infectious diseases will continue to fuel pharmaceutical sales.


Over recent years, the African pharmaceutical sector has seen steady development, thanks in part to increased investment by regional governments in public health initiatives and healthcare infrastructure. Ensuring the secure and timely delivery of essential medicines has become a key priority, creating attractive opportunities for local manufacturers and distributors. Moreover, the rollout of pooled procurement mechanisms is expected to further strengthen market access for generic drug makers, encouraging plant expansions and technology transfer in several countries. In South Africa specifically, the establishment of organized cancer‑screening programs is anticipated to boost demand for oncology drugs.


Key Market Trends & Insights

  • Country Leadership: South Africa led the regional market in 2023 with a 5% share, supported by its growing—and increasingly aging—population, wider private health insurance coverage, and higher patient volumes at both general practitioner and specialist clinics.

  • Molecule Type: Conventional (small‑molecule) drugs dominated with a 2% revenue share in 2023, owing to well‑established manufacturing capabilities, predictable pharmacokinetics, and strong oral bioavailability.
  • Branded vs. Generics: The branded pharmaceuticals segment captured 2% of revenues in 2023, reflecting continued investment in R&D, a surge in novel drug approvals, and patient demand for innovative therapies.
  • Prescription Medicines: The prescription segment accounted for 0% of the market in 2023, driven by increased R&D spending among leading pharmaceutical companies and the growing prevalence of chronic diseases requiring medical oversight.
  • Therapeutic Focus: Cancer therapies held the largest share by disease category at 5%, as governments implement preventive strategies, enhance diagnostic rates, and improve treatment access for oncology patients.
  • Route of Administration: Oral delivery dominated with a 0% share, attributable to its non‑invasive nature, rapid bioavailability, and higher patient adherence.
  • Dosage Form: Tablets were the most widely used dosage form, commanding a 1% share in 2023, thanks to their ease of administration and cost‑effectiveness.
  • Patient Demographics: The adult population segment represented the largest end‑user group in 2023 and is expected to grow the fastest, reflecting increased prevalence of chronic conditions among both middle‑aged and elderly demographics.
  • End‑Use Channel: Hospitals dominated distribution, accounting for 3% of market revenues in 2023, supported by rising public and private investment in healthcare facilities, upgrades to existing infrastructure, and growing demand for inpatient and outpatient clinical services.


Order a free sample PDF of the Africa Pharmaceutical Market Intelligence Study, published by Grand View Research.


Market Size & Forecast

  • 2023 Market Size: USD 85 Billion
  • 2030 Projected Market Size: USD 06 Billion
  • CAGR (2024-2030): 81 %
  • South Africa: Largest market in 2023
  • Nigeria: Fastest growing market


Key Africa Pharmaceutical Company Insights

The prominent companies of the country include Abbott, AbbVie, Aspen, Novartis Pfizer Laboratories, and more. These market players constantly engage in strategic initiatives, merger and acquisition activities, and regional expansion. For instance, in May 2023, the BRICS Health and Pharmaceutical Association of Africa announced an agreement to improve healthcare systems in Africa.


Key Players

  • Abbott Laboratories
  • AbbVie
  • Alfasigma
  • Aspen
  • Aurobindo Pharma
  • AstraZeneca
  • Bristol Myers Squibb
  • BGM
  • Cipla
  • Sun Pharma
  • BAYER

 

Browse Horizon Databook on Durable South Africa Pharmaceutical Market Size & Outlook


Conclusion

With strong macro‑health trends—rising chronic and infectious disease burdens, expanding healthcare infrastructure, and proactive government policies—the Africa pharmaceutical market is set for sustained double‑digit growth over the coming years. Continued improvements in procurement systems and local manufacturing capacity will further cement the region’s role as an emerging pharmaceutical hub.

Comments

Post a Comment

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

T he global  potash market  size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.   Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced...
Read more

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

  The global smart ticketing market size is expected to reach USD 31.65 billion by 2030, growing at a CAGR of 15.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. With the widespread adoption of smartphones, mobile ticketing channels have gained traction, allowing users to purchase, store, and validate tickets directly on their mobile devices, eliminating the need for physical cards or paper tickets. The convenience and ease of use offered by mobile ticketing have contributed to the growth of the market. Smart ticketing systems generate vast amounts of data on passenger journeys, travel patterns, and ticket usage.   Operators leverage this data to gain valuable insights, optimize operations, and improve the overall passenger experience. Data analytics techniques, such as predictive modeling and real-time monitoring, are being applied to enhance efficiency, manage capacity, and offer personalized services, which bode well for smart ticketing...
Read more

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts

  The  India foliar fertilizer market  size is expected to reach USD 4.9 billion by 2030, expanding at a CAGR of 11.3% during the forecast period, as per a new report by Grand View Research, Inc. The industry growth is majorly driven by surged demand for food due to increasing population coupled with supportive government initiatives and decreasing arable land in the country.   There has been a significant increase in the global prices of fertilizers and foliar fertilizers. As such, farmers falling into small- and marginal-income categories cannot afford to buy fertilizers resulting in reduced agricultural yields. This has led the Government of India to take initiatives to provide fertilizer subsidies to farmers in the country to make them affordable at subsidized prices. For instance, the Government of India announced a subsidy scheme related to fertilizers worth USD 27 billion in 2022 to ensure that fertilizers are affordable for every farmer in the country. Thus, ...
Read more